{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T13:18:28Z","timestamp":1794921508934,"version":"4.9.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ajo.2026.10.007","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:08:25Z","timestamp":1792451305000},"page":"89-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Risk Factors for Retinal Pigment Epithelium Tears in Patients With Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"293","author":[{"given":"Salem Abu","family":"Al-Burak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sarraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizan","family":"Naveed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaliy","family":"Voznyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouad","family":"Elganga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyran","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mihalache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Kertes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev H.","family":"Muni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SriniVas R.","family":"Sadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Feo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0370-5968","authenticated-orcid":false,"given":"Marko M.","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2026.10.007_bib0001","first-page":"142","article-title":"Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis)","volume":"112","author":"Sarraf","year":"2014","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"7","key":"10.1016\/j.ajo.2026.10.007_bib0002","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/IAE.0b013e3180342c42","article-title":"RPE tears after pegaptanib treatment in age-related macular degeneration","volume":"27","author":"Chang","year":"2007","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2026.10.007_bib0003","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s40135-014-0057-1","article-title":"Retinal pigment epithelium tear","volume":"3","author":"Rachitskaya","year":"2015","journal-title":"Curr Ophthalmol Rep"},{"issue":"9","key":"10.1016\/j.ajo.2026.10.007_bib0004","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/eye.2011.146","article-title":"Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD","volume":"25","author":"Gutfleisch","year":"2011","journal-title":"Eye (Lond)"},{"issue":"4","key":"10.1016\/j.ajo.2026.10.007_bib0005","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/IAE.0000000000002029","article-title":"Incidence and long-term visual acuity outcomes of retinal pigment epithelium tears after intravitreal anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration","volume":"39","author":"Vazquez-Alfageme","year":"2019","journal-title":"Retina"},{"issue":"17","key":"10.1016\/j.ajo.2026.10.007_bib0006","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.3390\/jcm12175496","article-title":"Clinical characteristics of eyes with neovascular age-related macular degeneration and retinal pigment epithelium tears","volume":"12","author":"Nagata","year":"2023","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.ajo.2026.10.007_bib0007","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/bjo.65.6.417","article-title":"Tears of detached retinal pigment epithelium","volume":"65","author":"Hoskin","year":"1981","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.10.007_bib0008","article-title":"Spontaneous massive retinal pigment epithelium tear: a case report of a dramatic complication of age-related macular degeneration","volume":"16","author":"Correia Barbosa","year":"2024","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.ajo.2026.10.007_bib0009","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ajo.2015.02.020","article-title":"Progression of retinal pigment epithelial atrophy in antiangiogenic therapy of neovascular age-related macular degeneration","volume":"159","author":"Sch\u00fctze","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.10.007_bib0010","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.survophthal.2017.03.004","article-title":"Retinal pigment epithelium tears: classification, pathogenesis, predictors, and management","volume":"62","author":"Ersoz","year":"2017","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.10.007_bib0011","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ajo.2013.06.024","article-title":"Mechanism of retinal pigment epithelium tear formation following intravitreal anti\u2013vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography","volume":"156","author":"Nagiel","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.10.007_bib0012","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1874364101408010101","article-title":"Incidence of retinal pigment epithelial tears and associated risk factors after treatment of age-related macular degeneration with intravitreal anti-VEGF injections","volume":"8","author":"Empeslidis","year":"2014","journal-title":"Open Ophthalmol J"},{"issue":"9","key":"10.1016\/j.ajo.2026.10.007_bib0013","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/IAE.0b013e31817d5d03","article-title":"Predictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysis","volume":"28","author":"Chiang","year":"2008","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.ajo.2026.10.007_bib0014","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/IAE.0000000000003083","article-title":"Management of retinal pigment epithelium tear during anti-vascular endothelial growth factor therapy","volume":"41","author":"Mitchell","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2026.10.007_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4367631","article-title":"Epidemiological and clinical baseline characteristics as predictive biomarkers of response to anti-VEGF treatment in patients with neovascular AMD","volume":"2016","author":"Tsilimbaris","year":"2016","journal-title":"J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.10.007_bib0016","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/IAE.0000000000003426","article-title":"Predictors of retinal pigment epithelium tear development after treatment for neovascular age-related macular degeneration using swept source optical coherence tomography angiography","volume":"42","author":"Yasuhara","year":"2022","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ajo.2026.10.007_bib0017","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/IAE.0000000000003922","article-title":"Association between retinal pigment epithelium tear and anti-vascular endothelial growth factor therapy: a systematic review and meta-analysis","volume":"44","author":"Shi","year":"2024","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.ajo.2026.10.007_bib0018","first-page":"1","article-title":"Long-term follow-up and regeneration of retinal pigment epithelium (RPE) after tears of the epithelium in exudative age-related macular degeneration (AMD)","volume":"40","author":"Mavridou","year":"2025","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.ajo.2026.10.007_bib0019","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2026.10.007_bib0020","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2026.10.007_bib0021","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"7650","key":"10.1016\/j.ajo.2026.10.007_bib0022","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ajo.2026.10.007_bib0023","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ajo.2007.03.024","article-title":"Retinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachment","volume":"144","author":"Weinberger","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2026.10.007_bib0024","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1007\/s00417-024-06503-z","article-title":"The factors associated with retinal pigment epithelium tear development in the early phase after treatment initiation for age-related macular degeneration","volume":"262","author":"Shiose","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2026.10.007_bib0025","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/IAE.0b013e31828992f5","article-title":"Prospective evaluation of the incidence and risk factors for the development of RPE tears after high- and low-dose ranibizumab therapy","volume":"33","author":"Sarraf","year":"2013","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.ajo.2026.10.007_bib0026","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/eye.2008.145","article-title":"Can the risk of retinal pigment epithelium tears after bevacizumab treatment be predicted? an optical coherence tomography study","volume":"22","author":"Leitritz","year":"2008","journal-title":"Eye (Lond)"},{"issue":"04","key":"10.1016\/j.ajo.2026.10.007_bib0027","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1055\/s-0034-1368219","article-title":"Retinal pigment epithelium rips after ranibizumab in neovascular age-related macular degeneration: incidence, risk factors and long-term outcome","volume":"231","author":"Guber","year":"2014","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"3","key":"10.1016\/j.ajo.2026.10.007_bib0028","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/sj.eye.6703098","article-title":"Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration","volume":"23","author":"Gelisken","year":"2009","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.ajo.2026.10.007_bib0029","doi-asserted-by":"crossref","first-page":"CR32","DOI":"10.12659\/MSM.882198","article-title":"Retinal pigment epithelial tears following ranibizumab therapy for fibrovascular retinal pigment epithelial detachment due to occult age-related macular degeneration","volume":"18","author":"Figurska","year":"2012","journal-title":"Med Sci Monit"},{"issue":"6","key":"10.1016\/j.ajo.2026.10.007_bib0030","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/IAE.0000000000000056","article-title":"Pigment epithelial tears associated with anti-VEGF therapy: incidence, long-term visual outcome, and relationship with pigment epithelial detachment in age-related macular degeneration","volume":"34","author":"Doguizi","year":"2014","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2026.10.007_bib0031","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1111\/aos.12234","article-title":"Prediction of retinal pigment epithelial tear in serous vascularized pigment epithelium detachment","volume":"92","author":"Clemens","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2026.10.007_bib0032","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1097\/IAE.0000000000001009","article-title":"Retinal pigment epithelial tear after intravitreal ranibizumab treatment for neovascular age-related macular degeneration","volume":"36","author":"Cho","year":"2016","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.ajo.2026.10.007_bib0033","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/IAE.0b013e3180cc2612","article-title":"Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration","volume":"27","author":"Chan","year":"2007","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ajo.2026.10.007_bib0034","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/IAE.0b013e3181babda5","article-title":"Optical coherence tomography\u2013measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections","volume":"30","author":"Chan","year":"2010","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2026.10.007_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000514991","article-title":"Retinal pigment epithelium tears after anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration","volume":"245","author":"Ahn","year":"2022","journal-title":"Ophthalmologica"},{"issue":"7","key":"10.1016\/j.ajo.2026.10.007_bib0036","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/IAE.0b013e3181cdf366","article-title":"A new grading system for retinal pigment epithelial tears","volume":"30","author":"Sarraf","year":"2010","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.ajo.2026.10.007_bib0037","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1097\/IAE.0000000000001062","article-title":"Double retinal pigment epithelium tears in neovascular age-related macular degeneration","volume":"36","author":"Mouallem","year":"2016","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.ajo.2026.10.007_bib0038","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.ajpath.2025.05.004","article-title":"The angiofibrotic switch in retinal and choroidal vascular diseases: mechanistic drivers of angiogenesis and endothelial-mesenchymal transition","volume":"195","author":"McLellan","year":"2025","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.ajo.2026.10.007_bib0039","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.3390\/ijms19113363","article-title":"The controversial role of TGF-\u03b2 in neovascular age-related macular degeneration pathogenesis","volume":"19","author":"Tosi","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ajo.2026.10.007_bib0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41598-022-27078-x","article-title":"Pigment epithelial detachment composition indices (PEDCI) in neovascular age-related macular degeneration","volume":"13","author":"Selvam","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2026.10.007_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1017889","article-title":"Ocular adverse events associated with anti-VEGF therapy: a pharmacovigilance study of the FDA adverse event reporting system (FAERS)","volume":"13","author":"Ma","year":"2022","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.ajo.2026.10.007_bib0042","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.ophtha.2016.07.007","article-title":"Ranibizumab treatment for pigment epithelial detachment secondary to neovascular age-related macular degeneration: post hoc analysis of the HARBOR study","volume":"123","author":"Sarraf","year":"2016","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2026.10.007_bib0043","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ophtha.2019.08.023","article-title":"Macular atrophy in neovascular age-related macular degeneration: a randomized clinical trial comparing ranibizumab and aflibercept (RIVAL study)","volume":"127","author":"Gillies","year":"2020","journal-title":"Ophthalmology"},{"issue":"10326","key":"10.1016\/j.ajo.2026.10.007_bib0044","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","article-title":"Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials","volume":"399","author":"Heier","year":"2022","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.ajo.2026.10.007_bib0045","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.3390\/jcm14196712","article-title":"Efficacy and safety of intravitreal faricimab in age-related macular degeneration\u2014a review","volume":"14","author":"Chan","year":"2025","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.ajo.2026.10.007_bib0046","article-title":"Aflibercept for neovascular age-related macular degeneration","volume":"2","author":"Sarwar","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.ajo.2026.10.007_bib0047","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.ophtha.2024.06.011","article-title":"International classification system for ocular complications of anti-VEGF agents in clinical trials","volume":"131","author":"Popovic","year":"2024","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2026.10.007_bib0048","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000529930","article-title":"Old problem in a new guise: retinal pigment epithelium tear after intravitreal faricimab (Vabysmo\u00ae) injection","volume":"14","author":"Clemens","year":"2023","journal-title":"Case Rep Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426005623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426005623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:36:09Z","timestamp":1794918969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426005623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":48,"alternative-id":["S0002939426005623"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.10.007","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Retinal Pigment Epithelium Tears in Patients With Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}